Debora Capelli

1.0k total citations
27 papers, 542 citations indexed

About

Debora Capelli is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Debora Capelli has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 13 papers in Oncology and 9 papers in Genetics. Recurrent topics in Debora Capelli's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Debora Capelli is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Debora Capelli collaborates with scholars based in Italy, United Kingdom and Russia. Debora Capelli's co-authors include Attilio Olivieri, Mauro Montanari, Marino Brunori, Antonella Poloni, Massimo Offidani, Pietro Leoni, Marco Candela, Moira Lucesole, Federico Mosna and Michele Gottardi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Debora Capelli

27 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debora Capelli Italy	14	390	199	175	133	83	27	542
Kang Howson‐Jan Canada	12	404 1.0×	203 1.0×	137 0.8×	189 1.4×	56 0.7×	33	666
Daniela Hoehn United States	15	257 0.7×	199 1.0×	276 1.6×	188 1.4×	78 0.9×	50	674
M Masi Italy	13	458 1.2×	129 0.6×	218 1.2×	105 0.8×	130 1.6×	26	597
R. Schlenk Germany	10	473 1.2×	96 0.5×	183 1.0×	139 1.0×	180 2.2×	20	629
Kátia Bórgia Barbosa Pagnano Brazil	13	384 1.0×	118 0.6×	163 0.9×	290 2.2×	85 1.0×	90	569
Hai‐Rong Qiu China	13	216 0.6×	150 0.8×	171 1.0×	211 1.6×	60 0.7×	60	498
Laurence Detourmignies France	9	237 0.6×	100 0.5×	195 1.1×	70 0.5×	86 1.0×	16	402
Mónica Cabrero Spain	11	382 1.0×	93 0.5×	145 0.8×	106 0.8×	48 0.6×	33	558
Salvatore Palmieri Italy	16	687 1.8×	214 1.1×	262 1.5×	148 1.1×	171 2.1×	47	815
A Granda Spain	9	397 1.0×	159 0.8×	98 0.6×	113 0.8×	39 0.5×	11	447

Countries citing papers authored by Debora Capelli

Since Specialization

Citations

This map shows the geographic impact of Debora Capelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora Capelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora Capelli more than expected).

Fields of papers citing papers by Debora Capelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora Capelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora Capelli. The network helps show where Debora Capelli may publish in the future.

Co-authorship network of co-authors of Debora Capelli

This figure shows the co-authorship network connecting the top 25 collaborators of Debora Capelli. A scholar is included among the top collaborators of Debora Capelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora Capelli. Debora Capelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Capelli, Debora. (2024). FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets. Cancers. 16(10). 1819–1819. 2 indexed citations

Capelli, Debora, Francesco Saraceni, Alessandro Fiorentini, et al.. (2020). Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment. Advances in Therapy. 37(5). 2288–2302. 5 indexed citations

Fiorentini, Alessandro, et al.. (2020). The Time Has Come for Targeted Therapies for AML: Lights and Shadows. SHILAP Revista de lepidopterología. 8(1). 13–32. 29 indexed citations

Costantini, Andrea, Giorgia Mancini, Jacopo Olivieri, et al.. (2020). A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. Transfusion. 60(7). 1529–1535. 4 indexed citations

Mosna, Federico, Cristina Papayannidis, Giovanni Martinelli, et al.. (2015). Complex karyotype, older age, and reduced first‐line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long‐term follow‐up. American Journal of Hematology. 90(6). 515–523. 45 indexed citations

Lacetera, Vito, Guido Gini, Debora Capelli, et al.. (2014). Primary B-cell lymphoblastic lymphoma of the testis. Archivio Italiano di Urologia e Andrologia. 86(4). 400–400. 2 indexed citations

Capelli, Debora, Martina Chiarucci, Antonella Poloni, et al.. (2014). Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin. Biology of Blood and Marrow Transplantation. 20(9). 1399–1406. 8 indexed citations

Olivieri, Attilio, Debora Capelli, Antonella Poloni, et al.. (2007). A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. Experimental Hematology. 35(7). 1074–1082. 5 indexed citations

Visani, Giuseppe, Attilio Olivieri, Michele Malagola, et al.. (2006). Consolidation therapy for adult acute myeloid leukemia: A systematic analysis according to evidence based medicine. Leukemia & lymphoma. 47(6). 1091–1102. 8 indexed citations

10.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2006). Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.. PubMed. 91(1). 133–6. 62 indexed citations

11.

Olivieri, Attilio, Moira Lucesole, Debora Capelli, et al.. (2005). A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(8). 627–636. 15 indexed citations

12.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2005). Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.. Blood. 106(11). 2558–2558. 1 indexed citations

13.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2004). Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma. The Hematology Journal. 5(4). 312–317. 21 indexed citations

14.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy. European Journal Of Haematology. 72(6). 403–409. 34 indexed citations

15.

Olivieri, Attilio, Ilaria Scortechini, Debora Capelli, et al.. (2004). Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. Bone Marrow Transplantation. 34(8). 693–702. 6 indexed citations

16.

Olivieri, Attilio, Marino Brunori, Debora Capelli, et al.. (2003). Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. European Journal Of Haematology. 72(1). 10–17. 40 indexed citations

17.

Montanari, Mauro, Debora Capelli, Antonella Poloni, et al.. (2003). Long‐term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled‐rate freezing and uncontrolled‐rate freezing at 80°C. Transfusion. 43(1). 42–49. 34 indexed citations

18.

Olivieri, Attilio, Debora Capelli, Mauro Montanari, et al.. (2001). Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplantation. 27(11). 1189–1195. 32 indexed citations

19.

Dazzi, Francesco, Robert P. Hasserjian, Myrtle Y. Gordon, et al.. (2000). Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation. The Hematology Journal. 1(5). 307–315. 17 indexed citations

20.

Capelli, Debora, Gino Santini, Cármino Antônio De Souza, et al.. (2000). Amifostine can reduce mucosal damage after high‐dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study. British Journal of Haematology. 110(2). 300–307. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact